Yıl: 2021 Cilt: 30 Sayı: 2 Sayfa Aralığı: 139 - 145 Metin Dili: İngilizce DOI: 10.37845/ret.vit.2021.30.24 İndeks Tarihi: 18-05-2022

The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy

Öz:
Purpose: This study was conducted to evaluate the ability of multicolor (MC)–green re flectance (GR) imaging in detecting retinal non- perfused areas (RNPAs) of eyes with diabetic retinopathy (DR). Materials and Methods: Fifty-five degrees fundus fluorescein angiography (FA) and MC imaging were performed in eyes with DR. Images were divided into four fields as macular, nasal, superior temporal, and inferior temporal. To determine the presence and size of RNPAs, FA images were examined by a retina specialist and MC–GR images were examined independently by two masked retina specialists. The compliance of RNPAs in FA and MC–GR images and the agreement of retina specialists were analyzed. Results: The FA and MC–GR images of the 178 eyes were analyzed. When GR images were compared to FA images in terms of RNPAs, sensitivity was 87%; specificity was 89%; the positive predictive value was 92%; the negative predictive value was 83%; and the accuracy was 87%. A substantial agreement was observed between two retina specialists in all retinal fields. Conclusion: This study showed that 55º MC–GR imaging could be an alternative to FA in the evaluation of RNPAs. This study is the first known to explore this issue and needs to be supported and developed with new investigations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. Idris I, Donnelly R. Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathy. Diab Vasc Dis Res 2006;3:172-178.
  • 2. Retinal Vascular Disease: Diabetic Retinopathy. In: Hermann D, Schubert MD, eds. American Academy of Ophtalmology Basic and Clinical Science Course, Section 12: Retina and Vitreus. AAO, San Francisco (CA), 2014;105-28.
  • 3. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care 2003;26 Suppl 1:S99-S102.
  • 4. Diabetic Retinopathy. In: Kanski JJ, ed. Kanski’s Clinical Ophthalmology, 6th ed. Elsevier, London (UK), 2007;566-84.
  • 5. Tan AC, Fleckenstein M, Schmitz-Valckenberg S, et al. Clinical Application of Multicolor Imaging Technology. Ophthalmologica 2016;236:8-18.
  • 6. Sergott RC. Retinal segmentation using multicolor laser imaging. J Neuroophthalmol 2014;34 Suppl:S24-28.
  • 7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
  • 8. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2015;30;2:17.
  • 9. Fong DS, Aiello LP, Ferris III FL, et al. Diabetic retinopathy. Diabetes Care 2004;27:2540-53.
  • 10. Bresnick GH, De Venecia G, Myers FL, et al. Retinal ischemia in diabetic retinopathy. Archives of ophthalmology 1975;93:1300-10.
  • 11. Chew EY, Ferris III FL. Nonproliferative Diabetic Retinopathy. In: Ryan SJ, ed. Retina, 4th ed. Elsevier Mosby, China, 2006;1271-84.
  • 12. Ffytche TJ, Shilling JS, Chisholm IH, et al. Indications for fluorescein angiography in disease of the ocular fundus: a review. J R Soc Med 1980;73:362-65.
  • 13. Butner RW, McPherson AR Adverse reactions in intravenous fluorescein angiography. Ann Ophthalmol 1983;15:1084-6.
  • 14. Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions afterfluorescein angiography. Results of a prospective study. Ophthalmology 1991;98:1139-42.
  • 15. Xu K, Tzankova V, Li C, Sharma S. Intravenous fluorescein angiography-associated adverse reactions. Can J Ophthalmol 2016;51:321-5.
  • 16. Feng HL, Sharma S, Stinnett S, et al. Identi fication of Posterior Segment Pathology with En Face Retinal Imaging Using Multicolor Confocal Scanning Laser Ophthalmoscopy. Retina 2019;39:972-9.
  • 17. Li S, Wang X, Du X, et al. Clinical application of multicolour scanning laser imaging in diabetic retinopathy. Lasers Med Sci 2018;33:1371-9.
  • 18. Roy R, Saurabh K, Thomas NR, et al. Validation of Multicolor Imaging of Diabetic Retinopathy Lesions Vis a Vis Conventional Color Fundus Photographs. Ophthalmic Surg Lasers Imaging Retina 2019;50:8-15.
  • 19. Lee J, Rosen R. Optical Coherence Tomography Angiography in Diabetes. Curr Diab Rep 2016;16:123.
  • 20. Garcia JM, Lima TT, Louzada RN, et al. Diabetic Macular Ischemia Diagnosis: Comparison between Optical Coherence Tomography Angiography and Fluorescein Angiography. J Ophthalmol 2016:3989310.
  • 21. Byeon SH, Chu YK, Lee H, et al. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Ophthalmology 2009;116:1949-1959.e8.
  • 22. Wessel MM, Nair N, Aaker GD, et al. Peripheral retinal ischaemia, as evaluated by ultra-wide field fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 2012;96:694-8 . 23. Sim DA, Keane PA, Rajendram R, et al. Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-wide field fluorescein angiography. Am J Ophthalmol 2014;158:144-153.e1.
  • 24. Pang CE, Freund KB. Ghost maculopathy: an artifact on near- infrared re flectance and multicolor imaging masquerading as chorioretinal pathology. Am J Ophthalmol 2014;158:171-178. e2.
APA KONUK S, YÜCEL Ö, ÖZTÜRK H, SÜLLÜ Y (2021). The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. , 139 - 145. 10.37845/ret.vit.2021.30.24
Chicago KONUK Serife Gülhan,YÜCEL Özlem ESKİ,ÖZTÜRK Hilal Eser,SÜLLÜ Yüksel The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. (2021): 139 - 145. 10.37845/ret.vit.2021.30.24
MLA KONUK Serife Gülhan,YÜCEL Özlem ESKİ,ÖZTÜRK Hilal Eser,SÜLLÜ Yüksel The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. , 2021, ss.139 - 145. 10.37845/ret.vit.2021.30.24
AMA KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. . 2021; 139 - 145. 10.37845/ret.vit.2021.30.24
Vancouver KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. . 2021; 139 - 145. 10.37845/ret.vit.2021.30.24
IEEE KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y "The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy." , ss.139 - 145, 2021. 10.37845/ret.vit.2021.30.24
ISNAD KONUK, Serife Gülhan vd. "The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy". (2021), 139-145. https://doi.org/10.37845/ret.vit.2021.30.24
APA KONUK S, YÜCEL Ö, ÖZTÜRK H, SÜLLÜ Y (2021). The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. Retina-Vitreus, 30(2), 139 - 145. 10.37845/ret.vit.2021.30.24
Chicago KONUK Serife Gülhan,YÜCEL Özlem ESKİ,ÖZTÜRK Hilal Eser,SÜLLÜ Yüksel The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. Retina-Vitreus 30, no.2 (2021): 139 - 145. 10.37845/ret.vit.2021.30.24
MLA KONUK Serife Gülhan,YÜCEL Özlem ESKİ,ÖZTÜRK Hilal Eser,SÜLLÜ Yüksel The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. Retina-Vitreus, vol.30, no.2, 2021, ss.139 - 145. 10.37845/ret.vit.2021.30.24
AMA KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. Retina-Vitreus. 2021; 30(2): 139 - 145. 10.37845/ret.vit.2021.30.24
Vancouver KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy. Retina-Vitreus. 2021; 30(2): 139 - 145. 10.37845/ret.vit.2021.30.24
IEEE KONUK S,YÜCEL Ö,ÖZTÜRK H,SÜLLÜ Y "The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy." Retina-Vitreus, 30, ss.139 - 145, 2021. 10.37845/ret.vit.2021.30.24
ISNAD KONUK, Serife Gülhan vd. "The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy". Retina-Vitreus 30/2 (2021), 139-145. https://doi.org/10.37845/ret.vit.2021.30.24